Large animal models for stem cell therapy

Stem Cell Research and Therapy

Volumn 4, Issue 2, 2013, Pages

  Harding, John ^a   Roberts, R Michael ^b   Mirochnitchenko, Oleg ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CHIMERA; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DNA MODIFICATION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYONIC STEM CELL; EXPERIMENTAL ANIMAL; HUMAN; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; LARGE ANIMAL MODEL; MEDICAL RESEARCH; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOARTHRITIS; PARKINSON DISEASE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETINA INJURY; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENIC ANIMAL; XENOTRANSPLANTATION; ANIMAL; CARDIOVASCULAR DISEASES; CYTOLOGY; EYE DISEASES; MUSCULOSKELETAL DISEASES; NERVOUS SYSTEM DISEASES; XENOGRAFT;

ANIMALIA; CANIS FAMILIARIS; CAPRA HIRCUS; ORYCTOLAGUS CUNICULUS; OVIS ARIES; PRIMATES; RODENTIA; SUIDAE;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; EYE DISEASES; HUMANS; MUSCULOSKELETAL DISEASES; NERVOUS SYSTEM DISEASES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875699329     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt171     Document Type: Review

References (50)

1. Preclinical assessment of stem cell therapies for neurological diseases. Joers VL, Emborg ME, ILAR J 2009 51 24 41 20075496
2. Chronic spinal compression model in minipigs: a systematic behavioral, qualitative, and quantitative neuropathological study. Navarro R, Juhas S, Keshavarzi S, Juhasova J, Motlik J, Johe K, Marsala S, Scadeng M, Lazar P, Tomori Z, Schulteis G, Beattie M, Ciacci JD, Marsala M, J Neurotrauma 2012 29 499 513 10.1089/neu.2011.2076 22029501
3. Concise review: toward stem cell-based therapies for retinal neurodegenerative diseases. Bull ND, Martin KR, Stem Cells 2011 29 1170 1175 10.1002/stem.676 21674700
4. Airway disease: the use of large animal models for drug discovery. Van der Velden J, Snibson KJ, Pulm Pharmacol Ther 2011 24 525 532 10.1016/j.pupt.2011.02.001 21356324
5. Large animal induced pluripotent stem cells as pre-clinical models for studying human disease. Plews JR, Gu M, Longaker MT, Wu JC, J Cell Mol Med 2012 16 1196 1202 10.1111/j.1582-4934.2012.01521.x 22212700
6. Imaging technique in large animals. Alstrup AK, Winterdahl M, Scand J Lab Anim Sci 2009 36 55 66
7. Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury? Yang PC, Circulation 2012 126 388 390 10.1161/CIRCULATIONAHA.112.119305 22767660
8. Porcine induced pluripotent stem cells analogous to naive and primed embryonic stem cells of the mouse. Telugu BP, Ezashi T, Roberts RM, Int J Dev Biol 2010 54 1703 1711 10.1387/ijdb.103200bt 21305472
9. Isolation and in vitro characterization of putative porcine embryonic stem cells from cloned embryos treated with trichostatin A. Vassiliev I, Vassilieva S, Truong KP, Beebe LF, McIlfatrick SM, Harrison SJ, Nottle MB, Cell Reprogram 2011 13 205 213 10.1089/cell.2010.0102 21548828
10. Application of genetically modified and cloned pigs in translational research. Matsunari H, Nagashima H, J Reprod Dev 2009 55 225 230 10.1262/jrd.20164 19571468
11. Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human beta1 and alpha2 integrin. Staunstrup NH, Madsen J, Primo MN, Li J, Liu Y, Kragh PM, Li R, Schmidt M, Purup S, Dagnæs-Hansen F, Svensson L, Petersen TK, Callesen H, Bolund L, Mikkelsen JG, PLoS One 2012 7 36658 10.1371/journal.pone.0036658 22590584
12. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB Jr, Zabner J, Prather RS, Welsh MJ, Science 2008 321 1837 1841 10.1126/science.1163600 18818360
13. Generation of an inbred miniature pig model of retinitis pigmentosa. Ross JW, Fernandez de Castro JP, Zhao J, Samuel M, Walters E, Rios C, Bray-Ward P, Jones BW, Marc RE, Wang W, Zhou L, Noel JM, McCall MA, DeMarco PJ, Prather RS, Kaplan HJ, Invest Ophthalmol Vis Sci 2012 53 501 507 10.1167/iovs.11-8784 22247487
14. Genetic modification of pigs as organ donors for xenotransplantation. Klymiuk N, Aigner B, Brem G, Wolf E, Mol Reprod Dev 2010 77 209 221 19998476
15. Induced pluripotent stem cells from pigs and other ungulate species: an alternative to embryonic stem cells? Ezashi T, Telugu BP, Roberts RM, Reprod Domest Anim 2012 47 Suppl 4 92 97 22827356
16. Chimeric animal models in human stem cell biology. Glover JC, Boulland JL, Halasi G, Kasumacic N, ILAR J 2009 51 62 73 20075498
17. Engraftment potential of adipose tissue-derived human mesenchymal stem cells after transplantation in the fetal rabbit. Martinez-Gonzalez I, Moreno R, Petriz J, Gratacos E, Aran JM, Stem Cells Dev 2012 21 3270 3277 10.1089/scd.2012.0032 22738094
18. Successful multilineage engraftment of human cord blood cells in pigs after in utero transplantation. Fujiki Y, Fukawa K, Kameyama K, Kudo O, Onodera M, Nakamura Y, Yagami K, Shiina Y, Hamada H, Shibuya A, Nakauchi H, Transplantation 2003 75 916 922 12698074 (Pubitemid 36438516)
19. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. Zanjani ED, Pallavicini MG, Ascensao JL, Flake AW, Langlois RG, Reitsma M, MacKintosh FR, Stutes D, Harrison MR, Tavassoli M, J Clin Invest 1992 89 1178 1188 10.1172/JCI115701 1348253
20. In utero transplantation of human hematopoetic stem cells into fetal goats under B-type ultrasonographic scan: an experimental model for the study of potential prenatal therapy. Zeng F, Chen MJ, Huang WY, Yan JB, Xiao YP, Gong ZJ, Ren ZR, Huang SZ, Eur J Obstet Gynecol Reprod Biol 2005 118 170 173 10.1016/j.ejogrb.2004.05.011 15653198 (Pubitemid 40093829)
21. In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Harrison MR, Slotnick RN, Crombleholme TM, Golbus MS, Tarantal AF, Zanjani ED, Lancet 1989 2 1425 1427 2574363 (Pubitemid 20012061)
22. Immunoregulatory properties of neural stem cells. Michel-Monigadon D, Brachet P, Neveu I, Naveilhan P, Immunotherapy 2011 3 39 41 10.2217/imt.11.49 21524169
23. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. Le Bas-Bernardet S, Tillou X, Poirier N, Dilek N, Chatelais M, Devallière J, Charreau B, Minault D, Hervouet J, Renaudin K, Crossan C, Scobie L, Cowan PJ, d'Apice AJ, Galli C, Cozzi E, Soulillou JP, Vanhove B, Blancho G, Transplant Proc 2011 43 3426 3430 10.1016/j.transproceed.2011.09.024 22099813
24. Immunogenicity of induced pluripotent stem cells. Zhao T, Zhang ZN, Rong Z, Xu Y, Nature 2011 474 212 215 10.1038/nature10135 21572395
25. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Poncelet AJ, Vercruysse J, Saliez A, Gianello P, Transplantation 2007 83 783 790 10.1097/01.tp.0000258649.23081.a3 17414713 (Pubitemid 46569198)
26. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR, Cell Transplant 2006 15 711 721 10.3727/000000006783981503 17269442 (Pubitemid 46095254)
27. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM, Blood 2002 99 3838 3843 10.1182/blood.V99.10.3838 11986244 (Pubitemid 34534559)
28. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Li J, Ezzelarab MB, Cooper DK, Xenotransplantation 2012 19 273 285 10.1111/xen.12000 22978461
29. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Lin CS, Lin G, Lue TF, Stem Cells Dev 2012 21 2770 2778 10.1089/scd.2012.0176 22621212
30. Corneal reconstruction with tissue-engineered cell sheets composed of human immature dental pulp stem cells. Gomes JA, Geraldes Monteiro B, Melo GB, Smith RL, Cavenaghi Pereira da Silva M, Lizier NF, Kerkis A, Cerruti H, Kerkis I, Invest Ophthalmol Vis Sci 2010 51 1408 1414 10.1167/iovs.09-4029 19892864
31. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Zhou L, Wang W, Liu Y, Fernandez de Castro J, Ezashi T, Telugu BP, Roberts RM, Kaplan HJ, Dean DC, Stem Cells 2011 29 972 980 10.1002/stem.637 21491544
32. Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates. Emborg ME, Joers V, Fisher R, Brunner K, Carter V, Ross C, Raghavan R, Brady M, Raschke J, Kubota K, Alexander A, Cell Transplant 2010 19 1587 1597 10.3727/096368910X514323 20587170
33. Transplantation of embryonic stem cell-derived dopaminergic neurons in MPTP-treated monkeys. Takahashi J, Takagi Y, Saiki H, Methods Mol Biol 2009 482 199 212 10.1007/978-1-59745-060-7-13 19089358
34. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR Jr, Sidman RL, Snyder EY, Proc Natl Acad Sci USA 2007 104 12175 12180 10.1073/pnas.0704091104 17586681 (Pubitemid 47185649)
35. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Bjugstad KB, Redmond DE Jr, Teng YD, Elsworth JD, Roth RH, Blanchard BC, Snyder EY, Sladek JR Jr, Cell Transplant 2005 14 183 192 10.3727/000000005783983098 15929553 (Pubitemid 40677148)
36. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Emborg ME, Ebert AD, Moirano J, Peng S, Suzuki M, Capowski E, Joers V, Roitberg BZ, Aebischer P, Svendsen CN, Cell Transplant 2008 17 383 395 18522241 (Pubitemid 351717341)
37. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N, J Clin Invest 2005 115 102 109 15630449 (Pubitemid 40385510)
38. Tabar V, Studer L: Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, Carrillo-Reid L, Auyeung G, Antonacci C, Buch A, Yang L, Beal MF, Surmeier DJ, Kordower JH, Nature 2011 480 547 551 22056989
39. Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. Daadi MM, Grueter BA, Malenka RC, Redmond DE Jr, Steinberg GK, PLoS One 2012 7 41120 10.1371/journal.pone.0041120 22815935
40. Cellular repair in the parkinsonian nonhuman primate brain. Redmond DE Jr, Weiss S, Elsworth JD, Roth RH, Wakeman DR, Bjugstad KB, Collier TJ, Blanchard BC, Teng YD, Synder EY, Sladek JR Jr, Rejuvenation Res 2010 13 188 194 10.1089/rej.2009.0960 20370501
41. Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. Sasaki M, Honmou O, Radtke C, Kocsis JD, PLoS One 2011 6 26577 10.1371/journal.pone.0026577 22039510
42. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, Di Bella S, Piccione G, Cell Biol Int 2012 36 189 194 10.1042/CBI20110304 21936851
43. Animal models for cartilage regeneration and repair. Chu CR, Szczodry M, Bruno S, Tissue Eng Part B Rev 2010 16 105 115 10.1089/ten.teb.2009.0452 19831641
44. Human Adipose-Derived Mesenchymal Stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Vieira NM, Valadares M, Zucconi E, Secco M, Bueno Junior CR, Brandalise V, Assoni A, Gomes J, Landini V, Andrade T, Caetano HV, Vainzof M, Zatz M, Cell Transplant 2012 21 1407 1417 10.3727/096368911X 23168016
45. Large animal models for cardiac stem cell therapies. Gandolfi F, Vanelli A, Pennarossa G, Rahaman M, Acocella F, Brevini TA, Theriogenology 2011 75 1416 1425 10.1016/j.theriogenology.2011.01.026 21463721
46. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. Amado LC, Schuleri KH, Saliaris AP, Boyle AJ, Helm R, Oskouei B, Centola M, Eneboe V, Young R, Lima JA, Lardo AC, Heldman AW, Hare JM, J Am Coll Cardiol 2006 48 2116 2124 10.1016/j.jacc.2006.06.073 17113001 (Pubitemid 44738440)
47. Translational findings from cardiovascular stem cell research. Mazhari R, Hare JM, Trends Cardiovasc Med 2012 22 1 6 10.1016/j.tcm.2012.05.017 22940024
48. Human relevance of pre-clinical studies in stem cell therapy: systematic review and metaanalysis of large animal models of ischaemic heart disease. van der Spoel TI, Jansen of Lorkeers SJ, Agostoni P, van Belle E, Gyongyosi M, Sluijter JP, Cramer MJ, Doevendans PA, Chamuleau SA, Cardiovasc Res 2011 91 649 658 10.1093/cvr/cvr113 21498423
49. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW, Circulation 2003 107 2290 2293 10.1161/01.CIR.0000070931.62772.4E 12732608 (Pubitemid 36578497)
50. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, 'off-the-shelf', cellular cardiomyoplasty strategy. Poh KK, Sperry E, Young RG, Freyman T, Barringhaus KG, Thompson CA, Int J Cardiol 2007 117 360 364 10.1016/j.ijcard.2006.04.092 16889857 (Pubitemid 46507628)